Telomir Pharmaceuticals Inc (TELO)

Feb 05, 2026

What are the risks of holding Telomir Pharmaceuticals IncChart Signals & Daily Growth Stock Investment Tips - baoquankhu1.vn

Feb 05, 2026

Feb 05, 2026

Telomir Pharmaceuticals Reports New Data Supporting an Epigenetic Modulation Mechanism Implicated in Cancer and Aging - accessnewswire.com

Feb 05, 2026

Feb 05, 2026

Telomir Pharmaceuticals Highlights Preclinical Data for Telomir-1 - TipRanks

Feb 05, 2026

Feb 05, 2026

Experimental Telomir-Zn compound rebalances metals tied to cancer and aging - stocktitan.net

Feb 05, 2026

Feb 05, 2026

Telomir Pharmaceuticals Reports New Cellular Data on Epigenetic Modulation - TradingView

Feb 05, 2026

Feb 02, 2026

Telomir Pharmaceuticals Reports Favorable IND-Enabling GLP Safety Results for Telomir-1 Supporting First-in-Human Clinical Development - Hillsdale Daily News

Feb 02, 2026

Jan 31, 2026

Setup Watch: Can Telomir Pharmaceuticals Inc outperform under higher oil pricesJuly 2025 Selloffs & Expert Approved Momentum Trade Ideas - baoquankhu1.vn

Jan 31, 2026

Jan 31, 2026

US Market Wrap: Is SIGA in a consolidation phasePortfolio Update Summary & Low Drawdown Investment Strategies - baoquankhu1.vn

Jan 31, 2026

Jan 30, 2026

Telomir Pharmaceuticals Inc. (TELO) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Jan 30, 2026

Jan 29, 2026

Is Telomir Pharmaceuticals Inc. a cyclical or defensive stockJuly 2025 Review & Growth Focused Stock Reports - mfd.ru

Jan 29, 2026

Jan 25, 2026

Insider Buy: How does Telomir Pharmaceuticals Inc compare to its peersRate Hike & Daily Profit Focused Screening - baoquankhu1.vn

Jan 25, 2026

Jan 21, 2026

Stock Analysis: How volatile is Telomir Pharmaceuticals Inc stockQuarterly Performance Summary & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn

Jan 21, 2026

Jan 19, 2026

Market Outlook: Is Telomir Pharmaceuticals Inc a cyclical or defensive stockWeekly Gains Report & Stepwise Trade Execution Plans - baoquankhu1.vn

Jan 19, 2026

Jan 18, 2026

Financial Survey: Telomir Pharmaceuticals (NASDAQ:TELO) versus electroCore (NASDAQ:ECOR) - Defense World

Jan 18, 2026

Jan 16, 2026

Gainers Report: What are the risks of holding Telomir Pharmaceuticals Inc2025 Stock Rankings & Daily Stock Trend Reports - baoquankhu1.vn

Jan 16, 2026

Jan 15, 2026

Will Telomir Pharmaceuticals Inc outperform small cap indexesJuly 2025 Review & Low Risk Entry Point Tips - baoquankhu1.vn

Jan 15, 2026

Jan 14, 2026

How does Telomir Pharmaceuticals Inc. compare to its peersJuly 2025 Weekly Recap & Technical Pattern Based Signals - bollywoodhelpline.com

Jan 14, 2026

Jan 13, 2026

Rodman & Renshaw initiates Telomir Pharma stock with Buy rating By Investing.com - Investing.com Canada

Jan 13, 2026

Jan 12, 2026

Aug Shorts: Is ImmuCell Corporation forming a bullish divergenceEarnings Overview Summary & Weekly Stock Breakout Alerts - baoquankhu1.vn

Jan 12, 2026

Jan 12, 2026

Telomir Pharmaceuticals Received Notice of Noncompliance - TradingView

Jan 12, 2026

Jan 10, 2026

Is Telomir Pharmaceuticals Inc. stock a top momentum playJuly 2025 Summary & Growth Focused Entry Point Reports - Улправда

Jan 10, 2026

Jan 10, 2026

Published on: 2026-01-10 12:17:57 - ulpravda.ru

Jan 10, 2026

Jan 09, 2026

Aug Movers: Why Telomir Pharmaceuticals Inc. stock is recommended by analystsGlobal Markets & Real-Time Market Trend Scan - ulpravda.ru

Jan 09, 2026

Jan 08, 2026

Is Telomir Pharmaceuticals Inc. stock in correction or buying zoneJuly 2025 Outlook & Advanced Swing Trade Entry Alerts - Улправда

Jan 08, 2026

Jan 08, 2026

Why retail investors favor Telomir Pharmaceuticals Inc. stockQuarterly Portfolio Summary & AI Forecast for Swing Trade Picks - Улправда

Jan 08, 2026

Jan 08, 2026

Trend Review: Why retail investors favor Telomir Pharmaceuticals Inc stockEarnings Growth Report & Step-by-Step Trade Execution Guides - Bộ Nội Vụ

Jan 08, 2026

Jan 08, 2026

Can Telomir Pharmaceuticals Inc. stock sustain revenue growthMerger & Acquisition Updates & Build Wealth With Expert Timing Advice - Улправда

Jan 08, 2026

Jan 07, 2026

Telomir Pharmaceuticals Announces Telomir-1 Significantly Reduced Tumor Growth and Metastases in Aggressive Triple-Negative Breast Cancer Animal Models - The Florida Times-Union

Jan 07, 2026

Jan 07, 2026

How Telomir Pharmaceuticals Inc. stock reacts to inflationary pressuresLow Risk Investment Ideas & Minimal Investment Portfolio Growth - ulpravda.ru

Jan 07, 2026

Jan 06, 2026

Telomir Pharmaceuticals reports preclinical results for Telomir-1 in TNBC models - Investing.com Australia

Jan 06, 2026

Jan 06, 2026

Coinbase CEO Brian Armstrong Says His Biotech Company Is Working On 'Extending' Human Lifespan: Here Is How They Plan To Do It - Benzinga

Jan 06, 2026

Jan 05, 2026

Telomir Highlights Positive Preclinical Results for Telomir-1 in TNBC - TipRanks

Jan 05, 2026

Jan 05, 2026

Telomir Pharmaceuticals Reports Positive Preclinical Results for Telomir-1 - TradingView — Track All Markets

Jan 05, 2026

Jan 05, 2026

Experimental breast cancer drug slows aggressive tumors in animal tests - Stock Titan

Jan 05, 2026

Jan 01, 2026

Is Telomir Pharmaceuticals Inc. stock positioned for digital transformationOptions Trading Strategies & Start Investing With Free Smart Watchlists - bollywoodhelpline.com

Jan 01, 2026

Jan 01, 2026

Telomir Pharmaceuticals reports preclinical results for Telomir-1 in TNBC models By Investing.com - Investing.com Nigeria

Jan 01, 2026

Dec 30, 2025

Telomir Pharmaceuticals (NASDAQ:TELO) Shares Down 8.9% – Here’s What Happened - Defense World

Dec 30, 2025

Dec 30, 2025

Telomir Pharmaceuticals (NASDAQ:TELO) Shares Down 8.9%Here's What Happened - MarketBeat

Dec 30, 2025

Dec 29, 2025

Is Telomir Pharmaceuticals Inc stock oversold or undervaluedRisk Management & Weekly Hot Stock Watchlists - moha.gov.vn

Dec 29, 2025